Leica Biosystems Nussloch GmbH

Company Overview

Leica Biosystems, a subsidiary of Danaher Corp., focuses on anatomical pathology solutions used in clinical and research laboratories. Its portfolio includes instruments, reagents, consumables, and software that support pathology workflows such as tissue processing, sectioning, staining, imaging, and slide management. It operates globally, serving hospitals, diagnostic laboratories, and research institutions involved in disease diagnosis and biomedical research.

In the context of noninvasive cancer diagnostics, Leica Biosystems contributes through digital pathology and imaging technologies that support cancer detection and analysis. Its slide scanners, image management systems, and pathology software enable digitization and standardized review of pathology samples, which can be integrated with AI-based tools for biomarker assessment and workflow efficiency. These technologies support cancer screening, diagnosis, and monitoring by enabling consistent analysis and data integration without adding invasive procedures beyond routine diagnostic sampling.

Company's Business Segments

• Anatomical Pathology Diagnostics : This segment provides products and solutions that support the preparation, analysis, and diagnosis of tissue samples, particularly for cancer and other diseases.